7,236 results match your criteria Transurethral Resection of the Prostate


Prostatic Artery Embolization Allows to Maintain Full Sexual Activity in Patients Suffering from Bothersome Lower Urinary Tracts Symptoms related to Benign Prostatic Hyperplasia.

Cardiovasc Intervent Radiol 2020 Jun 3. Epub 2020 Jun 3.

Faculté de Médecine, Université Paris V: René Descartes, Paris, France.

Introduction: The effect of prostate artery embolization (PAE) on male sexual function is currently the subject of debate in the literature. The main purpose of this study was to define changes in all domains of sexual activity after PAE, using the international index of erectile function score (IIEF-15).

Methods: A single-center retrospective study was conducted on 129 patients (mean age of 65. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-020-02520-7DOI Listing

Dural sac cross-sectional area is a highly effective parameter for spinal anesthesia in geriatric patients undergoing transurethral resection of the prostate: a prospective, double blinded, randomized study.

BMC Anesthesiol 2020 Jun 3;20(1):139. Epub 2020 Jun 3.

Department of Anesthesiology, The Affiliated AnQing Hospitals of Anhui Medical University, 352th, Renming Road, AnQing, 246003, AnHui province, China.

Background: Spinal anesthesia is optimal choice for transurethral resection of the prostate (TURP), but the sensory block should not cross the T10 level. With advancing age, the sensory blockade level increases after spinal injection in some patients with spinal canal stenosis. We optimize the dose of spinal anesthesia according to the decreased ratio of the dural sac cross-sectional area (DSCSA), the purpose of this study is to hypothesis that if DSCSA is an effective parameter to modify the dosage of spinal anesthetics to achieve a T10 blockade in geriatric patients undergoing TURP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12871-020-01059-xDOI Listing

Pitfalls of FDG-PET in the prostate for the surgical oncologist.

Urol Case Rep 2020 Nov 22;33:101262. Epub 2020 May 22.

Department of Surgery, University of Melbourne, Austin Hospital, Heidelberg, Australia.

A 78-year-old man was referred for investigation of prostate cancer following incidental uptake on 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). Despite normal PSA and benign digital rectal exam, he was referred for consideration of trans-perineal biopsy to exclude prostate cancer. It was only on review of imaging that it became clearly apparent that the 18F-FDG uptake was due to urinary tracer pooling in a trans-urethral resection cavity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eucr.2020.101262DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262006PMC
November 2020

Prostatic Artery Embolization for Benign Prostatic Hyperplasia Treatment: A Russian Multicenter Study in More Than 1,000 Treated Patients.

Am J Mens Health 2020 May-Jun;14(3):1557988320923910

Urology and Andrology Department, Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia.

Benign prostatic hyperplasia (BPH) is one of the most common diseases of the genitourinary system. The prevalence of BPH increases in men with advancing age. While transurethral resection of the prostate gland entails complications such as retrograde ejaculation, urinary incontinence, hematuria, urethral strictures, bladder neck sclerosis, and other adverse events, it is necessary to apply minimally invasive surgical methods such as superselective embolization of the prostatic arteries (PAE), particularly Proximal Embolization First Then Distal Embolization (PErFecTED). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1557988320923910DOI Listing

Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.

Radiat Oncol 2020 May 27;15(1):127. Epub 2020 May 27.

Department of Radiation Oncology, Kanagawa Cancer Center, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan.

Background: Carbon-ion radiotherapy (CIRT) for prostate cancer was initiated at Kanagawa Cancer Center in 2015. The present study analyzed the preliminary clinical outcomes of CIRT for prostate cancer.

Methods: The clinical outcomes of 253 patients with prostate cancer who were treated with CIRT delivered using the spot scanning method between December 2015 and December 2017 were retrospectively analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-020-01575-7DOI Listing

Risk assessment of neuromuscular stimulation by energy-based transurethral resection devices: an ex vivo test standard.

BMC Urol 2020 May 27;20(1):59. Epub 2020 May 27.

Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.

Background: During transurethral resection of bladder tumours (TURB), radio-frequency (RF) currents can lead to adverse neuromuscular stimulation (NMS). Here we present a novel ex vivo method to determine the risk of RF generators and their bipolar TURB modes to cause NMS. We aimed to develop an experimental platform for safety evaluation of new RF generators and their modes with a newly established test standard, suitable for replacement or reduction of animal testing. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12894-020-00630-5DOI Listing

The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.

Int J Surg 2020 May 21. Epub 2020 May 21.

Department of Uaffology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Electronic address:

Background: To compare the diagnostic value of prostate cancer (PCa) between holmium laser enucleation of the prostate (HoLEP) and transurethral resection of the prostate (TURP).

Methods: We retrospectively analyzed the clinical data of 2909 patients who underwent surgery for benign prostatic hyperplasia (BPH) from January 2008 to June 2018. A total of 1362 patients received HoLEP, and 1547 patients received TURP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijsu.2020.05.025DOI Listing

Significance of Paneth-cell-like differentiation in prostatic adenocarcinoma: A retrospective cohort study of 80 cases.

Hum Pathol 2020 May 20. Epub 2020 May 20.

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Departments of Urology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:

The grading and prognosis of prostatic adenocarcinoma with Paneth cell-like differentiation (PanEC) of the prostate is controversial with limited available data. We identified 80 cases, not previously published, of PanEC first identified on biopsy (n=69), transurethral resection (TURP)(n=1) and radical prostatectomy (RP) (n=10). Out of 69 biopsies, 22 did not have a grade assigned. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2020.05.003DOI Listing

Bipolar enucleation of the prostate-step by step.

Andrologia 2020 May 22:e13631. Epub 2020 May 22.

Department of Urology, Seoul National University Hospital, Seoul, Korea.

Bipolar enucleation of prostate (BipolEP) is a useful method for treatment of benign prostatic hyperplasia (BPH). Compared with conventional transurethral resection, the enucleation technique has several advantages. However, since the cost of laser equipment used for enucleation is relatively high, enucleation using bipolar devices has been attempted by many previous surgeons. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/and.13631DOI Listing

Risk Factors for Prostate Volume Progression After Prostate-Transurethral Resection.

Res Rep Urol 2020 5;12:175-178. Epub 2020 May 5.

Department of Anesthesiology, Faculty of Medicine, Udayana University, Bali, Indonesia.

Background: Many factors could contribute to the cases of residual benign prostate hypertrophy (BPH) volume after transurethral resection of the prostate (TURP), such as age, obesity, testosterone level, and inflammation. The goal of this study was to determine the risk of tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β) in prostate tissue, serum prostate-specific antigen (PSA), serum testosterone, and age in promoting prostate volume progression after TURP.

Patients And Methods: This was a prospective cohort study on 83 BPH patients who underwent TURP at five hospitals in Bali, Indonesia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/RRU.S249734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211307PMC

Urinary Reflux Into the Prostate Gland and Seminal Vesicles: A Potential Pitfall in 18F-FDG and 68Ga-PSMA PET/CT.

Clin Nucl Med 2020 Jul;45(7):536-537

From the Departments of Nuclear Medicine.

A 64-year-old man with lung cancer underwent F-FDG PET/CT for restaging, which demonstrated intense F-FDG uptake in the right lobe of prostate gland and seminal vesicles, indicating a potential prostate cancer. In Ga-PSMA PET/CT, intense uptake in the right lobe of prostate gland and seminal vesicles was also observed but decreased in postmictional delayed images. Magnetic resonance imaging showed high signal intensity of urine in the same areas of uptakes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000003069DOI Listing

Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP).

Front Oncol 2020 5;10:555. Epub 2020 May 5.

Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, United States.

Clinical data suggest that stereotactic body radiation therapy (SBRT) provides similar clinical outcomes as other radiation modalities for prostate cancer. However, data reporting on the safety of SBRT after TURP is limited. Herein, we report our experience using SBRT to deliver hypofractionated radiotherapy in patients with a history of TURP including physician-reported toxicities and patient-reported quality of life. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.00555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214538PMC

Detection of Prostatic Inflammation From Peripheral Lymphocyte Count and Free/Total PSA Ratio in Men With LUTS/BPH.

Front Pharmacol 2020 30;11:589. Epub 2020 Apr 30.

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

Objective: Identifying biomarkers of prostatic inflammation has been a question of great interest in the development of anti-inflammatory pharmacotherapy for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Systemic inflammation and serum prostate-specific antigen (PSA) have been linked with prostatic inflammation. This study set out to develop a diagnostic model for prostatic inflammation using clinical and laboratory parameters. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2020.00589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204507PMC

Lower Urinary Tract Symptoms Due to Xanthoma of the Prostate After Kidney Transplantation: A Case Report.

Transplant Proc 2020 May 15. Epub 2020 May 15.

Departments of Anatomic Pathology and Urology, School of Medical Sciences, State University of Campinas (Unicamp), Campinas, Brazil.

Background: Prostatic xanthoma is a lesion of unknown cause that is often an incidental finding in patients undergoing needle biopsy or transurethral resection. To the best of our knowledge, we report on a unique case of a pure xanthoma without benign prostatic hyperplasia of the prostate in a patient with lower urinary tract symptoms manifested after kidney transplantation.

Methods: A 62-year-old man was submitted for a kidney transplant in April 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2020.02.180DOI Listing

GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia.

Transl Androl Urol 2020 Apr;9(2):544-552

Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, China.

Background: Although the conventional, monopolar transurethral resection of the prostate (TURP) has proven to be an effective and relatively safe treatment for patients with benign prostatic hyperplasia (BPH), many new endoscopic technologies have been introduced to treat BPH. With the development of laser, there are several alternative transurethral procedures embracing laser therapies. Herein, this study sought to explore the efficacy, safety and follow-up of GreenLight laser photoselective vapo-enucleation of the prostate (PVEP) with front-firing emission compared with plasmakinetic resection of the prostate (PKRP) used to surgically manage BPH. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2020.02.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215003PMC

How to optimise urinary continence in anatomical endoscopic enucleation of the prostate?

Andrologia 2020 May 13:e13621. Epub 2020 May 13.

S.H. Ho Urology Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

The traditional transurethral resection of the prostate (TURP) is considered as gold-standard surgical treatment to relieve symptoms resulting from bladder outlet obstruction by prostate enlargement. However, with the advances of novel laser technologies and more experienced surgeon conquering the steep learning curve, anatomical endoscopic enucleation of prostate (AEEP) has become a more popular alternative surgical technique. Although AEEP has compatible functional outcome, less blood loss, shorter catheterisation duration and hospital stay, the risk of post-operative urinary incontinence (UI) is often an issue of concern. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/and.13621DOI Listing

Surgical Reintervention Rate after Prostatic Urethral Lift: Systematic Review and Meta-Analysis Involving over 2,000 Patients.

J Urol 2020 May 12:101097JU0000000000001132. Epub 2020 May 12.

Center for Male Health, Department of Urology, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois.

Purpose: The surgical reintervention rate after prostatic urethral lift (PUL) is not well characterized, but has been estimated at 2-3%/yr. We performed a systematic review and meta-analysis to determine the surgical reintervention rate after PUL.

Materials And Methods: We systematically searched Medline, Embase, and the Cochrane Central Register of Controlled Trials for studies of men treated with PUL reporting at least 1 year of maximum follow-up data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JU.0000000000001132DOI Listing

The relation between the storage symptoms before and after transurethral resection of the prostate, analysis of the risk factors and the prevention of the symptoms with solifenacin.

Int Braz J Urol 2020 Jul-Aug;46(4):575-584

Depertmen of Urology, Trakya University Medical Faculty, Edirne, Turkey.

Objective And Hypothesis: We aimed to investigate the reasons of storage symptoms ( SS) after transurethral resection of the prostate (TURP). The hypothesis was that a positive correlation would be identified between preoperative and postoperative SS in patients with undergoing TURP and starting early solifenacin treatment in patients with high preoperative SS would be reasonable. In addition, we aimed to analyze multiple other risk factors for post-TURP SS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0227DOI Listing

Usefulness of non-invasive cardiac output monitoring in elderly patients undergoing monopolar transurethral resection of the prostate: a pilot study.

J Int Med Res 2020 May;48(5):300060520922422

Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.

Objective: To assess the impact of irrigating fluid on hemodynamic profiles using real-time non-invasive cardiac output monitoring (NICOM) in elderly patients undergoing monopolar transurethral resection of the prostate (TURP).

Methods: Twenty patients between 65 and 80 years of age who were scheduled for monopolar TURP and received spinal anesthesia up to T10 were enrolled. Irrigating fluid (2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300060520922422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221478PMC

Management of highly recurrent bladder neck contractures via transurethral resection combined with intra- and post-operative triamcinolone acetonide injections.

World J Urol 2020 May 4. Epub 2020 May 4.

Department of Urology, The First Affiliated Hospital of Xian Jiaotong University, Xian, 710061, Shaanxi, China.

Purpose: To present our preliminary experience in managing patients with highly recurrent bladder neck contractures (BNCs) after transurethral resection of the prostate (TURP).

Methods: Between February 2015 and March 2018, 28 patients with highly recurrent BNCs who had failed multiple prior to endoscopic treatments were managed with transurethral resection and intra- and post-operative triamcinolone acetonide injections. The scar tissue was resected to the circular fiber at the bladder neck, and triamcinolone acetonide (2 mL, 40 mg/mL) was injected at the incision sites (8 points) using a cystoscopic injection needle. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-020-03224-wDOI Listing

Comparative Study of the Effectiveness and Safety of Transurethral Bipolar Plasmakinetic Enucleation of the Prostate and Transurethral Bipolar Plasmakinetic Resection of the Prostate for Massive Benign Prostate Hyperplasia (>80 ml).

Med Sci Monit 2020 Apr 27;26:e921272. Epub 2020 Apr 27.

Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China (mainland).

BACKGROUND The aim of this study was to compare the clinical safety and effectiveness of transurethral bipolar plasmakinetic enucleation of the prostate (PKEP) vs. transurethral bipolar plasmakinetic resection of the prostate (PKRP) in the treatment of benign prostate hyperplasia (BPH) more than 80 ml. MATERIAL AND METHODS From June 2015 to February 2019, 179 BPH patients with prostate volume greater than 80 ml were enrolled and separated into a PKEP (n=81) group and a PKRP group (n=98). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/MSM.921272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199430PMC

Successful transurethral resection of the prostate in ectopic prostate pheochromocytoma: A case report.

Medicine (Baltimore) 2020 Apr;99(17):e19852

Department of Medicine, Lishui Municipal Central Hospital, Lishui, Zhejiang Province.

Introduction: Most pheochromocytomas of the urinary tract are located in the bladder. However, ectopic prostate pheochromocytomas have rarely been reported. We herein report an unusual case of ectopic prostate pheochromocytoma successfully treated by transurethral resection of the prostate (TURP). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000019852DOI Listing

Assessment and Management of Urinary Dysfunction in 187 Patients with Parkinson's Disease.

J Parkinsons Dis 2020 Apr 13. Epub 2020 Apr 13.

Department of Urology, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China.

Background: Urinary dysfunction is common in Parkinson's disease (PD) patients and management options are limited.

Objective: This study aimed to explore the management of urinary dysfunction by researching the special needs of PD patients.

Methods: PD patients with urinary dysfunction who underwent urodynamic testing were recruited from a single center from October 2013 to February 2019. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-191806DOI Listing

Urine colour as an indicator for anastomotic leakage after robot-assisted radical prostatectomy.

Scand J Urol 2020 Apr 20:1-7. Epub 2020 Apr 20.

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

To determine whether macroscopic haematuria predicts urethrovesical anastomotic leakage after robot-assisted laparoscopic radical prostatectomy (RALP) as well as a cystogram. Participants were recruited before cystogram and catheter removal 5-14 days after RALP surgery. Urine colour in the collection bag was classified according to a three-step scale (clear, light red and dark red) and leakages in cystogram were graded with a four-step scale (Grade 0-3). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21681805.2020.1750474DOI Listing

Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer : Long-term results and factors predictive for outcome and toxicity.

Strahlenther Onkol 2020 Apr 17. Epub 2020 Apr 17.

Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Hospital-IRCCS, Via Manzoni 56, Rozzano, Milan, Italy.

Introduction: Stereotactic body radiation therapy (SBRT) is considered an effective and safe treatment in patients with low- and intermediate-risk prostate cancer (PC). However, due to a lack of long-term follow-up and late toxicity data, this treatment is not universally accepted. The present study aimed to evaluate outcome and early and late toxicity in a cohort of patients with low- and intermediate-risk PC treated prospectively with linear accelerator (linac)-based SBRT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-020-01619-7DOI Listing

The Importance of Cystoscopy in Diagnosis and Treatment of Urethral Stricture Following Transurethral Prostatectomy.

Isr Med Assoc J 2020 Apr;22(4):241-243

Department of Urology, Ziv Medical Center, affiliated with Azrieli Faculty of Medicine in the Galilee, Safed, Israel.

Background: Transurethral prostatectomy is the gold standard surgical treatment of bladder outlet obstruction due to benign enlargement of the prostate, with more than 30,000 procedures performed annually in the United States alone. The success rate of this minimally invasive procedure is high and the results are durable. The development of urethral stricture is a long-term complication of the procedure and is noted in about 2% of patients. Read More

View Article

Download full-text PDF

Source
April 2020
0.903 Impact Factor

[Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers].

Urologe A 2020 Apr 9. Epub 2020 Apr 9.

Dachverband der Prostatazentren Deutschlands e. V., Berlin, Deutschland.

Background: Due to the high incidence and demographic development, there is an urgent need for healthcare research data on lower urinary tract symptoms due to benign prostatic hyperplasia (LTUS/BPH). Since 2005 the Governing Body of German Prostate Centers (DVPZ) has been collecting data from 22 prostate centers in order to determine the quality and type of cross-sectoral care in particular for LUTS/BPH patients.

Objectives: Presentation of the DVPZ database in general, as well as an investigation of treatment patterns for medical and instrumental therapies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-020-01192-yDOI Listing

[Benign prostatic hyperplasia : New and treatment-relevant aspects from the DGU guidelines].

Urologe A 2020 May;59(5):544-549

Urologische Praxisgemeinschaft, Hamburg-Blankenese, Hamburg, Deutschland.

The diagnosis and treatment of lower urinary tract symptoms (LUTS) due to benign prostatic enlargement plays an important role in daily urological practice. Therefore, a targeted and resource-saving approach is essential. A rational base-line work-up of our patients provides the necessary information for obtaining the diagnosis and only needs to be expanded in individual cases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-020-01184-yDOI Listing

Is Holmium Laser Enucleation of the Prostate a Good Surgical Alternative in Benign Prostatic Hyperplasia Management? A Review Article.

J Lasers Med Sci 2020 15;11(2):197-203. Epub 2020 Mar 15.

Laser Application in Medical Science Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Several therapeutic approaches such as holmium laser enucleation of the prostate (HoLEP) have been introduced to relieve bladder outlet obstruction caused by benign prostatic hyperplasia (BPH). Compared with other techniques including the transurethral resection of the prostate (TURP) and simple open prostatectomy, HoLEP results in a shorter hospital stay and catheterization time and fewer blood loss and transfusions. HoLEP is a size-independent treatment option for BPH with average gland size from 36 g to 170 g. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.34172/jlms.2020.33DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118502PMC

Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.

J Vasc Interv Radiol 2020 Jun 2;31(6):882-890. Epub 2020 Apr 2.

Department of Urology, Complejo Hospitalario de Navarra, Pamplona, Spain.

Purpose: To compare clinical and functional outcomes of prostatic artery embolization (PAE) with those of transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

Materials And Methods: Noninferiority randomized trial was conducted involving men over 60 years of age with LUTS secondary to BPH. From November 2014 to January 2017, 45 patients were randomized to PAE (n = 23) or to TURP (n = 22). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2019.12.810DOI Listing

Impact on Sexual Function of Endoscopic Enucleation Transurethral Resection of the Prostate for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.

J Endourol 2020 May 5. Epub 2020 May 5.

Department of Urology, Peking University Third Hospital, Beijing, China.

Although the transurethral resection of the prostate (TURP) has been regarded as the gold standard surgical option for lower urinary tract symptoms due to benign prostatic hyperplasia, the endoscopic enucleation of the prostate (EEP) with novel techniques is also recommended. However, whether there are differences on male sexual functions after these two procedures is still controversial. We performed this meta-analysis to investigate the impact on erectile function (EF) and ejaculation of EEP and TURP, and to explore the potential superiority between these two approaches. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2020.0141DOI Listing

Vesico-urethral anastomotic stenosis following radical prostatectomy: a multi-institutional outcome analysis with a focus on endoscopic approach, surgical sequence, and the impact of radiation therapy.

World J Urol 2020 Mar 31. Epub 2020 Mar 31.

University Medical Centre Mannheim, Heidelberg University, Mannheim, Germany.

Objectives: To investigate the predictors of recurrence and of de novo incontinence in patients treated by transurethral incision or resection for vesico-urethral anastomotic stenosis (VUAS) after radical prostatectomy.

Material And Methods: All patients undergoing endoscopic treatment for VUAS between March 2009 and October 2016 were identified in our multi-institutional database. Digital chart reviews were performed and patients contacted for follow-up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-020-03157-4DOI Listing

Thulium Laser Vapoenucleation of the Prostate (ThuVEP) in Men at High Cardiovascular Risk and on Antithrombotic Therapy: A Single-Center Experience.

J Clin Med 2020 Mar 27;9(4). Epub 2020 Mar 27.

Department of Urology, IRCCS INRCA, 60127 Ancona, Italy.

Bleeding is the most common complication of transurethral resection of the prostate and simple open prostatectomy, especially in men on antiplatelet/anticoagulant therapy. The present study aimed to evaluate the safety and effectiveness of thulium laser vapoenucleation of the prostate (ThuVEP) for benign prostatic hyperplasia in patients on chronic antithrombotic medications. Between January 2015 and December 2019, 88 men underwent the procedure under antithrombotic agents in our center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9040917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231078PMC

[Monopolar transurethral enucleation and resection of the prostate: Status quo of its application and studies].

Zhonghua Nan Ke Xue 2019 Jun;25(6):566-571

Department of Urology, Chongqing Renji Hospital, University of Chinese Academy of Sciences, Chongqing 400062, China.

Transurethral enucleation of the prostate allows more complete excision of the proliferative glands at the anatomical level, and has its unique advantages over the traditional surgical procedures, such as better results of surgery, lower recurrence rate, and higher satisfaction of the patients. At present, transurethral laser enucleation of the prostate has a limited application in many grass-root hospitals for the high price of laser and plasma equipment and a high incidence rate of postoperative urinary incontinence. In this context, monopolar transurethral enucleation and resection of the prostate (mTUERP) has come into the attention of clinicians, which can be performed with the equipment for transurethral resection of the prostate (TURP) and may become a real alternative of TURP. Read More

View Article

Download full-text PDF

Source

[Transurethral holmium laser enucleation of the prostate for benign prostatic hyperplasia in patients with a history of transrectal prostate biopsy].

Zhonghua Nan Ke Xue 2019 May;25(5):403-407

Department of Urology, Wujin Hospital Affiliated to Jiangsu University, Changzhou, Jiangsu 213017, China.

Objective: To evaluate the efficiency and safety of transurethral holmium laser enucleation of the prostate (HoLEP) in the treatment of BPH in patients with a history of transrectal prostate biopsy (TRPB).

Methods: We retrospectively analyzed the clinical data on 102 cases of BPH treated by HoLEP in our hospital between November 2015 and May 2017, of which 42 had received TRPB prior to HoLEP (the PB group) but not the other 60 (the non-TRPB [NPB] group). We compared the preoperative, perioperative and postoperative follow-up data between the two groups of patients. Read More

View Article

Download full-text PDF

Source

[Surgical strategies for large-volume benign prostatic hyperplasia: How to choose?]

Authors:
Jun Mi Lin-Jun Wang

Zhonghua Nan Ke Xue 2019 May;25(5):387-391

Research Institute of Urology / Key Laboratory of Gansu Province for Urological Diseases / Gansu Clinical Center for Urological Diseases, The Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, China.

Transurethral resection of the prostate (TURP) is a gold standard for the treatment of BPH. However, for large-volume BPH, TURP has its disadvantages of longer operation time, more residual glands, more intraoperative bleeding, lower efficiency, and longer hospital stay, which increase the risks of surgery and postoperative symptomatic recurrence. Therefore, minimally invasive treatment of large-volume BPH remains a clinical challenge. Read More

View Article

Download full-text PDF

Source

[Transurethral holmium laser enucleation of the prostate combined with Jisheng Shenqi Decoction for benign prostatic hyperplasia].

Zhonghua Nan Ke Xue 2019 Apr;25(5):351-355

Department of Urology, Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine / Jiangsu Branch of Chinese Academy of Traditional Chinese Medicine / Jiangsu Research Institute of Traditional Chinese Medicine, Nanjing, Jiangsu 210028, China.

Objective: To assess the clinical effects of transurethral holmium laser enucleation of the prostate (HoLEP) combined with Jisheng Shenqi Decoction (HoLEP + JSSD) on BPH.

Methods: This study included 110 BPH patients treated in our hospital from August 2017 to April 2018, who were randomly assigned to receive HoLEP (n = 55) or HoLEP + JSSD (n = 55). We compared the pre- and post-operative IPSS, quality of life (QOL) score, prostate volume, postvoid residual urine volume (PVR), maximum urinary flow rate (Qmax), average urinary flow rate (Qavg) and levels of serum T, E2 and T/E2 as well as postoperative complications between the two groups of patients. Read More

View Article

Download full-text PDF

Source

The Management of Patients Diagnosed with Incidental Prostate Cancer: Narrative Review.

Res Rep Urol 2020 16;12:105-109. Epub 2020 Mar 16.

Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

5-14% of patients underwent surgery for benign prostate hyperplasia harboring prostate cancer (PCa) focus. The best management of incidental prostate cancer (iPCa) has been debated. The decision "treatment or no treatment" should be determined by predictors which accurately foretell PCa progression after transurethral resection of the prostate (TURP). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/RRU.S245669DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083625PMC

Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia.

Cochrane Database Syst Rev 2020 03 25;3:CD013251. Epub 2020 Mar 25.

Minneapolis VA Health Care System, Urology Section, One Veterans Drive, Mail Code 112D, Minneapolis, Minnesota, USA, 55417.

Background: New minimal invasive surgeries have been suggested as alternative options to transurethral resection of the prostate (TURP) for the management of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). Convective radiofrequency water vapour thermal therapy is a new technology that uses targeted, controlled water vapour energy (steam) to create necrotic tissue in the prostate.

Objectives: To assess the effects of convective radiofrequency water vapour thermal therapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD013251.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093307PMC

Surgical management of benign prostatic obstruction: 20-year population-level trends.

Can Urol Assoc J 2020 Mar 23. Epub 2020 Mar 23.

Division of Urology, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada.

Introduction: Benign prostatic obstruction (BPO) due to histologic benign prostatic hyperplasia is highly prevalent among older men. Despite widespread use of medical therapy, surgical treatment remains a mainstay in the management of BPO. We sought to characterize trends in the surgical management of BPO in Ontario, Canada. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.6224DOI Listing

Association between Inflammation and Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia.

Urol J 2020 Mar 14. Epub 2020 Mar 14.

Department of urology, Baotou central hospital, Botou014040, Inner Mongolia, China.

Purpose: To evaluate the association between inflammation in prostatic tissue/serum sample and BPH-LUTSPatients and methods: The prostatic tissue and serum sample were collected from 183 patients who underwent transurethral plasmakinetic resection of the prostate (TUPKRP).  The association between inflammation detected on prostatic tissues/ serum sample and LUTS related parameters, including International Prostate Symptom Score (IPSS) and peak flow rate (Qmax) were analyzed with SPSS version 13.0, and P-value <0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.22037/uj.v0i0.5462DOI Listing

Holmium laser enucleation of the prostate for very large benign prostatic hyperplasia (≥ 200 cc).

World J Urol 2020 Mar 23. Epub 2020 Mar 23.

Department of Urology, Mayo Clinic in Arizona, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA.

Purpose: Patients presenting with prostate gland sizes greater than 200 cc pose a unique surgical challenge to both patients and surgeons. The objective of this study is to critically assess the efficacy and risks associated with performing holmium laser enucleation of the prostate (HoLEP) on glands ≥ 200 cc.

Materials And Methods: Using a prospective maintained database, all consecutive benign prostatic hyperplasia (BPH) patients with gland size ≥ 200 cc who underwent HoLEP were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-020-03156-5DOI Listing

Electrocoagulation Accounts for a Significant Portion of Discrepancy Between Preoperative Ultrasonography Prostate Size Estimation and Resected Tissue Weight.

J Endourol 2020 Apr 22. Epub 2020 Apr 22.

Department of Neuroscience, University of Toronto, Toronto, Canada.

Transurethral resection of the prostate (TURP) is considered to be the gold standard surgical procedure for medium-sized prostates. However, there is a drastic difference between the weight of resected tissue reported by the pathologist and the sonographic estimate of prostate weight before the operation. The present study investigates the role of electrocoagulation in tissue loss during monopolar (M-) and bipolar (B-) TURP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2020.0037DOI Listing

Seminal Vesicle Involvement by Carcinoma In Situ of the Bladder: Clonal Analysis Using Next-Generation Sequencing to Elucidate the Mechanism of Tumor Spread.

Cancer Res Treat 2020 Mar 19. Epub 2020 Mar 19.

Department of Urology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea.

We present a rare case of urothelial carcinoma in situ (CIS), which invades the prostate and seminal vesicle (SV). A 70-year-old man underwent transurethral resection of bladder (TURB), and the pathologic examination revealed multiple CIS. Although the patient received intravesical bacillus Calmette-Guerin (BCG) therapy following TURB, recurrence of CIS was confirmed in the bladder and left distal ureter at 3 months following BCG. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2020.002DOI Listing

[Lower urinary tract symptoms after transurethral resection of the prostate].

Urologiia 2020 Mar(1):103-109

Urologic department 2 of GBUZ City clinical hospital named after D.D. Pletnev of the Health Department c. Moscow, Moscow, Russia.

An analysis of the frequency of residual lower urinary tract symptoms after surgical treatment is presented in this literature review. A special attention is paid to prognostic criteria for persistence of irritative symptoms after the surgery. The analysis of modern approaches to the treatment of urinary disturbances has been performed. Read More

View Article

Download full-text PDF

Source

A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial.

J Contemp Brachytherapy 2020 Feb 28;12(1):1-5. Epub 2020 Feb 28.

Mount Vernon Cancer Centre, Northwood, United Kingdom.

Purpose: Early reports suggested that transurethral resection (TURP) prior to permanent seed brachytherapy (BT) results in high incontinence rates. Guidelines consider prior TURP as a contra-indication to treatment, but improvements in imaging and treatment planning may reduce this risk, and are investigated in this prospective study.

Material And Methods: 99 men with histologically proven low- to intermediate-risk, localized prostate cancer, with a history of TURP performed at least 3 months before BT procedure were enrolled. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/jcb.2020.92913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073343PMC
February 2020

Recent advances in pediatric bladder malignancies.

F1000Res 2020 25;9. Epub 2020 Feb 25.

Division of Urology, The Hospital for Sick Children and Department of Surgery, University of Toronto, Toronto, ON, Canada.

Urothelial pediatric neoplasms are relatively rare. Papillary urothelial neoplasms of low malignant potential (PUNLMPs) and rhabdomyosarcoma (RMS) are the most common bladder malignancies in the pediatric population. Clinical presentation encompasses macroscopic hematuria or lower urinary tract symptoms (or both) or is detected incidentally at imaging. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.19396.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043112PMC
February 2020

Complications of anatomical endoscopic enucleation of the prostate.

Andrologia 2020 Mar 9:e13557. Epub 2020 Mar 9.

Department of Urology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Transurethral resection of the prostate (TURP) remains the 'gold standard' for surgical treatment of benign prostatic obstruction (BPO). Recently, anatomical endoscopic enucleation of the prostate (AEEP) using holmium laser, thulium laser and plasma, etc., is extensively applied in clinical practice. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/and.13557DOI Listing

[Effect of transition zone index on the outcome after transurethral resection of prostate].

Zhonghua Yi Xue Za Zhi 2020 Feb;100(6):452-455

Department of Urology, People's Hospital affiliated to Guizhou Medical University, Guiyang 550002, China.

To investgate the effect of properative transitional zone index (TZI) on the outcome of transurethral resection of prostate (TURP). A retrospective analysis was performed on 206 patients with TURP who were admitted to our hospital from January 2016 to September 2018. All patients underwent transrectal ultrasound (TRUS) to determine the total prostate volume (TPV) and the transition zone volume (TZV). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0376-2491.2020.06.011DOI Listing
February 2020